Evidence map›Paper›PMID 34306225›Full record

ArticleJournal of smoking cessation2021

Waterpipe Smoking among Bladder Cancer Patients: A Cross-Sectional Study of Lebanese and Jordanian Populations.

Elio Jabra, Amal Al-Omari, Fadi Haddadin, Walid Alam, Khawlah Ammar, Maya Charafeddine, Mohammad Alrawashdeh, Nour Kasasbeh, Charbel Habis, Deborah Mukherji and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of smoking cessation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Elio JabraDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Amal Al-OmariOffice of Scientific Affairs and Research, King Hussein Cancer Center (KHCC), Amman, Jordan.ORCID https://orcid.org/0000-0001-7571-3097
Fadi HaddadinDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Walid AlamDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.ORCID https://orcid.org/0000-0002-3714-6674
Khawlah AmmarOffice of Scientific Affairs and Research, King Hussein Cancer Center (KHCC), Amman, Jordan.
Maya CharafeddineDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.ORCID https://orcid.org/0000-0003-1270-610X
Mohammad AlrawashdehOffice of Scientific Affairs and Research, King Hussein Cancer Center (KHCC), Amman, Jordan.
Nour KasasbehOffice of Scientific Affairs and Research, King Hussein Cancer Center (KHCC), Amman, Jordan.ORCID https://orcid.org/0000-0002-5515-2381
Charbel HabisDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Deborah MukherjiDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Sally TemrazDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Ali ShamseddineDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.ORCID https://orcid.org/0000-0003-3725-8403
American University of Beirut Medical Center · LBKing Hussein Cancer Center · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBladder cancer (BC) is the second most reported cancer in Lebanon and the fifth in Jordan. Its risk factors are mainly smoking and occupational exposure to aromatic amines. In these countries where smoking and bladder cancer are highly prevalent, the role of waterpipe smoking (WPS) in bladder cancer is less investigated. We aim to compare two sets of patients between Lebanon and Jordan, focusing on their smoking habits, WP use, occupational exposure, and the grade/invasiveness of their bladder cancer.

methodsThis is a cross-sectional study that compares the smoking culture between two sets of populations with bladder cancer, from two different countries. We recruited 274 bladder cancer patients over the 18 years of age at the American University of Beirut Medical Center (AUBMC), and 158 bladder cancer patients over the age of 18 years at the King Hussein Cancer Center (KHCC).

results7.7% of Lebanese patients had significantly more positive family history of bladder cancer compared to 13.9% of Jordanian patients (

conclusionsBladder cancer incidence is on the rise in both Jordan and Lebanon along with different smoking types. It is necessary to impose prevention policies to prevent and control the high smoking prevalence. Bladder cancer invasiveness is higher in Jordan compared to universal data.

Identifiers

PMID34306225
PMCPMC8279186
OpenAlexW3156166818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.